National Stem Cell, Inc. Closes Private Placement
Published: Aug 21, 2006
NEW YORK--(BUSINESS WIRE)--Aug. 21, 2006--National Stem Cell, Inc., a biotechnology company, today announced the successful completion of a private placement of common stock to new and existing accredited investors. National Stem Cell is looking forward to completing its reverse merger with Azurel (ticker: AZUR) and accelerating its research mission.